TAI versus TAI plus H101 on NSCLC

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPN-15006746

Enrollment

Unknown

Registered

2015-07-11

Start date

2015-06-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none small cell lung cancer

Interventions

h101 plus TAI:h101 plus TAI

TAI:TAU

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: patients with NSCLC willing to enroll into this trail

Exclusion criteria

Exclusion criteria: 1. Allergic reactions to biological agents, hypersensitiveness; 2. Pregnancy and breast-feeding women; 3.Expected survival <3 month.

Design outcomes

Primary

Measure	Time frame
FPS;OS;	—

Countries

China

Contacts

Public ContactQing He

tonyhe11@sina.com+86 15928987207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026